openPR Logo
Press release

United States Skin Cancer Drugs Market Set to Surge: Innovative Therapies and Rising Awareness Drive Growth in 2025 | Major key players - Amgen Inc., Sanofi S.A., Novartis AG.

10-10-2025 01:46 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Skin Cancer Drugs Market

Skin Cancer Drugs Market

Market Overview:

The Skin Cancer Drugs Market is estimated to reach at a CAGR of 10.2% during the forecast period (2024-2031).

The Skin Cancer Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/skin-cancer-drugs-market?sz

The Skin Cancer Drugs Market encompasses the development, production, and commercialization of pharmaceutical treatments targeting various skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma. It includes targeted therapies, immunotherapies, and chemotherapeutic agents designed to inhibit cancer progression, improve patient survival, and enhance quality of life. Rising prevalence of skin cancers and advancements in drug development drive this market.

Industry Recent Developments:

USA:
✅ October 2025 - The FDA approved cemiplimab-rwlc for adjuvant treatment of cutaneous squamous cell carcinoma, indicating regulatory progress for new skin cancer drug treatments in the U.S. market.

✅ July 2025 - A new drug application for relacorilant was submitted to the FDA based on phase 3 clinical trial data (ROSELLA study), showcasing ongoing advancement in drug candidates targeting oncological conditions including skin cancer.

Japan:
✅ July 2025: Japanese researchers developed a new skin cancer drug based on genetically modified "viral therapy" that selectively attacks cancer cells. Early clinical tests showed promising improvement in 77.8% of patients when combined with conventional treatments.

✅ Early 2025: Japan's oncology drug market is growing due to aging population and rising cancer incidence, with targeted therapies expected to see significant CAGR growth. The government supports precision medicine and accelerated drug approvals.

Europe:
✅ September 2025: Europe's skin cancer drugs market is evolving with drivers including rising incidence, favorable regulations like the EU Cancer Plan, and increased healthcare spending. AI-powered tools are enhancing early detection and drug efficacy.

✅ September 2025: The European Medicines Agency (EMA) recommended 14 new medicines for approval, including several in oncology, showing regulatory momentum for new skin cancer drug introductions in the region.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/skin-cancer-drugs-market?sz

Major Key Players:

Amgen Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
Sanofi S.A.-
Merck & Co., Inc.
Novartis AG -
Sun Pharmaceutical Industries Ltd
Daiichi Sankyo Co.
GlaxoSmithKline.

Key Growth Drivers:

Rising Incidence of Skin Cancer - Increasing cases of melanoma and non-melanoma skin cancers globally are driving demand for effective treatments.

Advancements in Targeted Therapies and Immunotherapies - Innovative drugs, including immune checkpoint inhibitors and targeted therapies, are improving patient outcomes, boosting market growth.

Growing Awareness and Early Diagnosis - Enhanced public awareness, screening programs, and early detection initiatives are increasing treatment adoption rates.

Segments Covered in the Skin Cancer Drugs Market:

By Cancer Type: Melanoma, Non-melanoma.

By Drug Class: Chemotherapy, Immunotherapy, Targeted Therapy, Others.

By End-User Segment: Hospital, Clinics, Cancer Research Institutes, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=skin-cancer-drugs-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Skin Cancer Drugs market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Skin Cancer Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Skin Cancer Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Skin Cancer Drugs Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Skin Cancer Drugs Market in 2025?
◆ What is the projected growth rate of the Skin Cancer Drugs Market through 2033?
◆ Who are the key players in the Skin Cancer Drugs Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Skin Cancer Drugs Market Set to Surge: Innovative Therapies and Rising Awareness Drive Growth in 2025 | Major key players - Amgen Inc., Sanofi S.A., Novartis AG. here

News-ID: 4218123 • Views:

More Releases from DataM Intelligence 4Market Research

United States Quantum Computing in Financial Services Market is expected to reach US$ 2.5 billion by 2032 | Top key players - IBM Corporation, Intel Corporation, IonQ Inc.
United States Quantum Computing in Financial Services Market is expected to reac …
Market Size and Growth: Leander, Texas, The Quantum Computing in Financial Services Market Size reached US$ 0.3 billion in 2024 and is expected to reach US$ 6.3 billion by 2032, growing with a CAGR of 46.5% during the forecast period 2025-2032. The Market is growing rapidly due to increasing demand for ultra-fast data processing, complex financial modeling, and advanced risk management solutions in the financial sector. According to DataM Intelligence Get a
United States Rigid Polyurethane Foam Market Set to Soar: Key Growth Drivers Unveiled for 2025 | Major key players - Huntsman International LLC, BASF SE, Dow.
United States Rigid Polyurethane Foam Market Set to Soar: Key Growth Drivers Unv …
Market Overview: Leander, Texas, The Rigid Polyurethane Foam Market is expected to grow at a CAGR of 8.1% during the forecast period 2024-2031. The Market is growing due to rising demand for energy-efficient insulation in construction and increasing use in automotive and packaging applications. According to DataM Intelligence Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/rigid-polyurethane-foam-market?sz The Rigid Polyurethane Foam Market refers to the global industry involved in the production, distribution, and application of
United States Food Pathogen Testing Market is expected to reach US$ 3.19 billion by 2032 | Top key players - BioMerieux SA, Romer Labs, Bureau Veritas S.A.
United States Food Pathogen Testing Market is expected to reach US$ 3.19 billion …
Market Size and Growth: Leander, Texas, The Global Food Pathogen Testing Market Size reached US$ 6.60 billion in 2024, and is expected to reach US$ 12.20 billion by 2032, growing at a CAGR of 11.57% during the forecast period 2025-2032. The Market is growing due to increasing food safety regulations and rising consumer demand for contamination-free food products. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/food-pathogen-testing-market?sz The Food Pathogen Testing Market involves the global
United States Edge Computing for Autonomous Vehicles Market is expected to reach US$ 11.6 billion by 2032 | Top key players - NVIDIA Corporation, Tesla, Baidu Apollo.
United States Edge Computing for Autonomous Vehicles Market is expected to reach …
Market Size and Growth: The Global Edge Computing for Autonomous Vehicles Market Size reached US$ 7.64 billion in 2024 and is expected to reach US$ 39.00 billion by 2032, growing with a CAGR of 22.60% during the forecast period 2025-2032. The Market is growing due to the rising adoption of autonomous and connected vehicles, which require real-time data processing and low-latency edge computing for safer and faster decision-making. According to DataM

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For